Aevi Genomic Medicine Enters into License Agreement with AstraZeneca for Anti-IL-18 Antibody
Aevi Genomic Medicine, Inc. announced that it has obtained the right to exercise an exclusive...
Navigating Russia’s Compliance Regulations; Arguably the Most Complex in the World
Russia’s increasing reliance on pharmaceutical-driven healthcare is resulting in a growing consumer demand for drugs...
Lonza and AllCells Join Forces for Global Commercialization of Hematopoietic Primary Cells
Lonza and AllCells have entered into a private label partnership for the manufacture and global...
New Study Findings Show Mixture of DuPont Probiotic Strains and Lactoferrin Reduces Common Cause...
New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture...
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company...
Eisai and UCLommence preparations for phase i clinical studies in Alzheimer’s Disease for Novel...
Eisai Co., Ltd and University College London announced that they have commenced preparations for Phase...
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing...
Protagen AG collaborates with UCSF to study better immuno-profiling of cancer patients receiving immunotherapy
Protagen AG has announced the start of a collaboration with the University of California, San...
The Falsified Medicines Directive – are you ready?
The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require...
Stem Cell and Regenerative Therapies for Hearing Loss
The year 2018 marks a notable milestone in the history of stem cell and regenerative...